The largest database of trusted experimental protocols

Dotma

Manufactured by Avanti Polar Lipids
Sourced in United States

DOTMA is a synthetic lipid molecule commonly used in the formulation of liposomes for various research and laboratory applications. It serves as a cationic lipid component that can facilitate the encapsulation and delivery of genetic material, such as DNA or RNA, into cells. DOTMA's core function is to enable the formation of lipid-based vesicles that can be used for the study of membrane dynamics, drug delivery, and other experimental purposes.

Automatically generated - may contain errors

5 protocols using dotma

1

Cationic Liposome Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Materials DOTMA was purchased from Avanti Polar Lipids (Alabaster, AL, U.S.A.). Cholesterol, edaravone, 2′, 7′-dichlorofluorescin diacetate (DCFH-DA) were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.). Hoechst dye was purchased from Invitrogen (Burlington, ON, Canada). RAW264.7 mouse macrophage-like cell line was obtained from ATC C and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS).
Preparation of Cationic Liposomes Cationic liposomes were prepared as previously described. 20, (link)21) (link) Briefly, lipid components composed of DOTMA/Chol (50/50 mol%) were dissolved in ethanol at 20 mM of total lipid. The lipids etha-nol solution was mixed with distilled water through a staggered herringbone micromixer (SHM) at a total flow rate of 2 mL/min, and a flow rate ratio of 3 (v/v) (water/ethanol ratio). The resulting suspension was subsequently dialyzed against at least 1000-fold volume of distilled water overnight to remove the residual ethanol. Cationic liposomes solution was then filtered through a 0.2 µm filter.
+ Open protocol
+ Expand
2

Lipid-peptide-siRNA Nanoparticle Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOTMA, DOPE, DOPG, DPPE PEG 2000, and cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL, USA). The structures of the lipids, peptides, and siRNAs are shown in Table 1. Peptides Y (K16GACYGLPHKFCG), ME27 (K16RVRRGACRGDCLG), ME72 (K16RVRRGACRGECLG), KG31 (K16RXSXGACYGLPHKFCG, Hydrophobic Y, X = epsilon-aminohexanoic acid), and KG32 (K16RVRRGACYGLPHKFCG, Cleavable Y) were synthesized by ChinaPeptides (Shanghai, China) and AMS Biotechnology (Abingdon, UK). The siRNAs used in this study were custom synthesized and purchased from Dharmacon (Cambridge, UK). The siRNAs were dissolved in sterile RNase-free water at a concentration of 2.5 mg/mL.

Structures of the Different Lipids and Sequences of Peptides and siRNAs

+ Open protocol
+ Expand
3

Synthesis of RNA-Lipoplexes for Targeted Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipoplexes were manufactured by mixing cationic liposomes with the RNA using dedicated protocols as described previously [3 (link), 7 (link)]. Briefly, the RNA-lipoplexes were generated by dilution of RNA in H2O and 1.5 M NaCl prior to addition of liposomes to obtain the ratios given below and a final NaCl concentration of 150 mM. To formulate spleen-targeting RNA-lipoplexes, liposomes consist of a 2:1 (mol:mol) mixture of the synthetic cationic lipid 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA) (Merck & Cie, Schaffhausen, CH) and the phospholipid 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) (Avanti Polar Lipids, Alabaster, AL, USA, or Corden Pharma, Liestal, CH). To make the lung-targeting RNA-lipoplexes, liposomes consisting of DOTMA and cholesterol (Avanti Polar Lipids, Alabaster, AL, USA) at a 1:1 molar ratio were used.
The charge ratio for particle formation was calculated using the molar mass of 670 Da for the positively charged DOTMA and a mean molar mass of 330 Da for each negatively charged nucleotide of the RNA. For particles targeting the lung the charge ratio was 4:1, resulting in particles with an average size of ~ 260 nm and a polydispersity index of ~ 0,23. For particles to target the spleen the charge ratio was 1.3:2, resulting in an average size of ~ 250 nm and a polydispersity index of ~ 0,25.
+ Open protocol
+ Expand
4

Lipid Nanoparticle Delivery of Oligonucleotides

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOTMA and DOPE were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). Polyethylene glycol 6000 (PEG6000) was obtained from Sigma-Aldrich (St. Louis, MO, USA). Epi was purchased from Pfizer, Inc. (New York, NY, USA). ASOs were obtained from Scientific Biotech Corp. (Taipei, Taiwan). All cell culture medium and reagents were purchased from Promega (Madison, WI, USA), Invitrogen (Carlsbad, CA, USA), Gibco BRL (Grand Island, NY, USA), or Hyclone (Logan, UT, USA). Most of the other chemical reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) or Merck (Darmstadt, Germany).
+ Open protocol
+ Expand
5

Preparation and Characterization of Lipid-Inhibitor Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOTMA (1,2-di-O-octadecenyl-3-trimethylammonium propane) and DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) were purchased from Avanti Polar Lipids (Alabama, USA). CCG-222740 inhibitor was synthesised and characterised in the Vahlteich Medicinal Chemistry Core at the University of Michigan. The inhibitor was > 95% pure by high performance liquid chromatography (HPLC). HPLC grade (> 99% purity) solvents, including acetronitrile, trifluoroacetic acid, chloroform and methanol, were bought from Sigma, UK. All glassware was sterilised by autoclaving and procedures were performed under aseptic conditions in a cell culture hood.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!